Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Phase 3 trial (M12-665)
.
Show all posts
Showing posts with label
Phase 3 trial (M12-665)
.
Show all posts
Monday, August 6, 2012
Phase 3 Elagolix Trial Begins | News | Drug Discovery and Development Magazine
›
Elagolix (see structure) is an oral gonadotropin-releasing hormone (GnRH) antagonist. " Endometriosis can be a debilitating diseas...
›
Home
View web version
